ONdrugDelivery - Page 34 of 62 - ONdrugDelivery - drug delivery industry specialised b2b information

eTheRNA launches international consortium, starts development of cross-strain protective CoV-2 mRNA vaccine

eTheRNA launches international consortium, starts development of cross-strain protective CoV-2 mRNA vaccine

An international consortium is pooling resources to develop a nasally delivered, cross-strain protective CoV-2 mRNA vaccine. Clinical testing is scheduled for early 2021. Organisations involves include eTheRNA, EpiVax, REPROCELL, Nexelis, and CEV

Gerresheimer part of critical infrastructure, products include vital drug delivery devices

Gerresheimer part of critical infrastructure, products include vital drug delivery devices

In its COVID-19 announcement, Gerresheimer has stated that it is part of the critical infrastructure of the countries in which it operates, producing vital packaging for medicines, drug delivery devices and packaging for food, beverages and hygiene and personal care products.

Catalent Responds to the Global Outbreak of COVID-19

Catalent Pharma Solutions

Catalent Responds to the Global Outbreak of COVID-19

Catalent has noted that many governments of the countries where it operates have recognised its work as essential meaning all Catalent operating facilities remain open. The company also said it was working with several customers on COVID-related antivirals, vaccines, and treatments for symptoms and effects of the disease.

With precision metal components being used in inhalers & similar devices, Advanex acknowledges critical role in supply chain

With precision metal components being used in inhalers & similar devices, Advanex acknowledges critical role in supply chain

Advanex acknowledges critical role in supply chains with precision metal components being used in inhalers & similar devices, and commits to maintaining supply during turbulent period.

Elcam Medical facilities Recognised by local authorities as essential, enabling continuation of production

Elcam Medical facilities Recognised by local authorities as essential, enabling continuation of production

All Elcam facilities have been recognised by the local authorities as an essential facility to enable the continuity of production. (See statement by the Israeli Ministry of Economy and Industry). Currently the company does not foresee any disruption to our operation.

Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19

Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19

Lexaria is to investigate how its patented DehydraTECH drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories as soon as possible.

ACG releases letter to customers in response to COVID-19

ACG releases letter to customers in response to COVID-19

ACG has released a letter to its customers in response to the COVID-19 outbreak, and reaffirmed its commitment to providing uninterrupted supply of its products and services, and factories in all locations around the world are working at full capacity. ACG has also ensured the supply of its own raw materials for many months.

PFIZER OUTLINES FIVE-POINT PLAN TO BATTLE COVID-19

PFIZER OUTLINES FIVE-POINT PLAN TO BATTLE COVID-19

Pfizer has called on the biopharmaceutical industry to join it in committing to unprecedented collaboration to combat COVID-19, issuing a five-point plan, which includes applying its drug development expertise, especially to help smaller companies, and offering its manufacturing capabilities.

Nemera highlights obligation to provide life-saving devices to most vulnerable – including the elderly, asthmatics, diabetics

Nemera highlights obligation to provide life-saving devices to most vulnerable – including the elderly, asthmatics, diabetics

PRESS RELEASE In its COVID-19 press update, Nemera has highlighted its obligation to provide life-saving […]

The world in a state of emergency: How Sensirion helps save lives worldwide

The world in a state of emergency: How Sensirion helps save lives worldwide

Sensirion is lending its support to manufacturers of respiratory devices around the world to ensure their equipment is fitted with exceptionally accurate sensor technology allowing for time-resolved flow and volume measurements.

Aptar Group Releases COVID-19 Update for its Customers and Partners

Aptar Group Releases COVID-19 Update for its Customers and Partners

Aptar Pharma has released a message from its President and Chief Executive Officer to provide a COVID-19 update to inform its customers and partners of the measures the Group is taking in regards to the evolving coronavirus pandemic in order to continue to support our customers.

AS DEMAND SURGES, NEPHRON PREPARED TO MEET AMERICA’S NEEDS FOR RESPIRATORY MEDS

AS DEMAND SURGES, NEPHRON PREPARED TO MEET AMERICA’S NEEDS FOR RESPIRATORY MEDS

Nephron Pharmaceuticals has released a statement detailing how current demand for its medications - inhalation solutions and suspension products that treat respiratory conditions - is surging and the company is shattering sales records.

US FDA Issues Guidance for Conducting Clinical Trials during the COVID-19 pandemic.

US FDA Issues Guidance for Conducting Clinical Trials during the COVID-19 pandemic.

“With this guidance issued today, the FDA is helping industry and investigators navigate the COVID-19 […]

PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products

PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products

PBOA reports how its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and report no material disruptions to their operations.

Insmed Provides Covid-19 Business Update

Insmed Provides Covid-19 Business Update

Insmed implements corporate initiatives in response to the novel coronavirus (SARS-CoV-2) global pandemic including a remote working policy to allow infectious disease specialists and pulmonologists to focus on treating patients and containing the virus. Arikares trainers will now offer remote training and onboarding for patients who initiate treatment with ARIKAYCE.

Beyond Air Submits Investigational Device Exemption to FDA for the Treatment of COVID-19

Beyond Air Submits Investigational Device Exemption to FDA for the Treatment of COVID-19

Beyond Air has submitted an IDE to the US FDA for use of its LungFit™ BRO system in the treatment of COVID-19 patients stating that a mounting body of evidence that NO is safe and well tolerated and in vitro evidence points to inhibition of viral replication in coronaviruses.

ADDRESSING COMPLEX BIOLOGICS WITH RATIONAL DRUG DEVICE DESIGN

PREFILLED SYRINGES

Gene Rhode Fuensalida Pantig

ADDRESSING COMPLEX BIOLOGICS WITH RATIONAL DRUG DEVICE DESIGN

Gene Rhode Fuensalida Pantig reviews drug development over the years, the discovery of biologics as therapeutic agents and the emergence of autoinjectors, in correspondence with Hans Lin, PhD, a Research Fellow from Academia Sinica, Taiwan.

ENHANCING THE PATIENT EXPERIENCE FOR SELF-INJECTION SYSTEMS

PREFILLED SYRINGES

ENHANCING THE PATIENT EXPERIENCE FOR SELF-INJECTION SYSTEMS

The complexity of injectable treatment regimens for chronic diseases means onboarding aids can be integral to disease management. Joe Reynolds discusses the role of demonstration devices in improving the patient experience and adherence.

HOW USERS DISTINGUISH BETWEEN SELF-INJECTION DEVICE PLATFORM VARIANTS

Dr Andreas Schneider

HOW USERS DISTINGUISH BETWEEN SELF-INJECTION DEVICE PLATFORM VARIANTS

Andreas Schneider highlights how the ever-increasing interest in device platforms raises concerns around the broad availability of lookalike autoinjectors that may result in inappropriate medication usage. He summarises a recent empirical study¹ providing insights into which device attributes drive device distinguishability.

DRUG DELIVERY DESIGNED TO IMPROVE THE PATIENT EXPERIENCE

Enable Injections

DRUG DELIVERY DESIGNED TO IMPROVE THE PATIENT EXPERIENCE

Jennifer King looks at the delivery challenges of novel therapies for chronic diseases using a specific patient’s story as an example, going on to highlight the ways in which a novel device approach could make all the difference for patients.

OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE

PREFILLED SYRINGES

Mitsubishi Gas Chemical

OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE

Shota Arakawa and Tomohiro Suzuki, discuss the benefits of the OXYCAPT™ multilayer plastic vial and syringe for the rapidly growing field of biologics and regenerative medicines.

CHOOSING THE RIGHT LABEL MATERIAL FOR PREFILLED SYRINGES

CHOOSING THE RIGHT LABEL MATERIAL FOR PREFILLED SYRINGES

Jos van Noort outlines some of the key factors that must be taken into consideration when selecting a label for prefillable syringes.

NEXT-GENERATION WEARABLE DELIVERY DEVICES FOR LARGE-VOLUME BIOLOGICS

NEXT-GENERATION WEARABLE DELIVERY DEVICES FOR LARGE-VOLUME BIOLOGICS

Thomas Mayer discusses Sonceboz’s platform of wearable injection devices for large-volume biologics, which can follow drugs from clinical trials to commercial phase through lifecycle management, which reduces risk and speeds time to market.

EU MDR: ANCILLARY DELIVERY DEVICES FACE EQUAL SCRUTINY TO STANDALONE MEDICAL DEVICES

EU MDR: ANCILLARY DELIVERY DEVICES FACE EQUAL SCRUTINY TO STANDALONE MEDICAL DEVICES

Elizma Parry offers her expertise and practical guidance to businesses hoping to achieve a CE mark for a medical device, with new EU regulations being implemented this year.

Prev
1
…
32
33
34
35
36
…
62
Next

See what ondrugdelivery's readers and contributors think

Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Top